Intellia Therapeutics, Inc.NTLANASDAQ
LOADING
|||
ROE: Returns Declining
Trending lower, below historical average, strong compound growth.
Left:
||||
Return on equity
Latest
-59.52%
↓ 87% below average
Average (9y)
-31.85%
Historical baseline
Range
High:-15.08%
Low:-59.52%
CAGR
+13.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -59.52% | -29.9% |
| 2023 | -45.82% | -19.4% |
| 2022 | -38.38% | -49.0% |
| 2021 | -25.75% | -1.1% |
| 2020 | -25.47% | +30.9% |
| 2019 | -36.88% | -20.1% |
| 2018 | -30.71% | -36.7% |
| 2017 | -22.47% | -49.0% |
| 2016 | -15.08% | +18.1% |
| 2015 | -18.41% | - |